You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Avonex®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial (Diroximel Fumarate, Avonex, Tysabri)

Not yet recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +3 more
  • (no location specified)
Dec 12, 2022

Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

Terminated
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Rockland, Massachusetts
  • +1 more
Jul 13, 2021

Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

Terminated
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Rockland, Massachusetts
  • +1 more
Jul 13, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Nizhny Novgorod (BCD-054 180 mcg, Avonex®, BCD-054 240 mcg)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • BCD-054 180 mcg
  • +3 more
  • Nizhny Novgorod, Russian Federation
    State Budgetary Healthcare Institution of Nizhny Novgorod region
Sep 6, 2021

Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)

Completed
Has Results
  • Multiple Sclerosis
  • Interferon beta 1a, oral doxycycline
  • Shreveport, Louisiana
    LSU Health Sciences Center Shreveport
Oct 11, 2022

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Relapsing Remitting Multiple Sclerosis Trial (Laquinimod, Avonex®)

Withdrawn
  • Relapsing Remitting Multiple Sclerosis
  • (no location specified)
Nov 5, 2021

Interferon Beta-1a on Changes of Non-conventional MRI Measures

Completed
  • Multiple Sclerosis
  • Avonex® monotherapy (6.0 MIU administered i.m. each week)
  • Buffalo, New York
    The Jacobs Neurological Institute
Dec 23, 2020

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

Not yet recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +5 more
  • Interferon Beta-1A
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Multiple Sclerosis Trial in Buffalo (repository corticotropin injection, Saline)

Withdrawn
  • Multiple Sclerosis
  • repository corticotropin injection
  • Saline
  • Buffalo, New York
    University at Buffalo, Buffalo General Hospital
Dec 30, 2020

Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Placebo
  • +3 more
  • (no location specified)
Mar 22, 2021

Multiple Sclerosis Trial in Worldwide (Laquinimod, Placebo, Avonex®)

Completed
Has Results
  • Multiple Sclerosis
  • Birmingham, Alabama
  • +169 more
Mar 23, 2022

Bioequivalence, Healthy Trial in Turku (Interferon Beta-1A)

Completed
  • Bioequivalence
  • Healthy
  • Interferon Beta-1A
  • Turku, Finland
    CRST Oy, Clinical Research Services Turku Itäinen Pitkäkatu 4 B,
Jan 8, 2020

Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Highly Effective Therapies Group
  • Escalation Therapies Group
  • Aurora, Colorado
  • +30 more
Jul 22, 2022

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (dimethyl fumarate, Interferon ß-1a)

Active, not recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • dimethyl fumarate
  • Interferon β-1a
  • Boston, Massachusetts
  • +61 more
Jan 12, 2022

Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Interferon-beta (IFN-beta))

Completed
Has Results
  • Multiple Sclerosis
  • Cullman, Alabama
  • +38 more
Oct 8, 2020

EPID Multiple Sclerosis Pregnancy Study

Completed
  • Multiple Sclerosis
  • Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG
  • +6 more
  • Multiple Locations, Finland
    Many locations
Aug 12, 2019

Relapsing Multiple Sclerosis Trial in Worldwide (Laquinimod)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • Homewood, Alabama
  • +143 more
Dec 7, 2021

Multiple Sclerosis, Exposure During Pregnancy Trial in Worldwide (Dimethyl fumarate, Peginterferon beta-1a)

Recruiting
  • Multiple Sclerosis
  • Exposure During Pregnancy
  • Dimethyl fumarate
  • Peginterferon beta-1a
  • Boston, Massachusetts
  • +16 more
Oct 21, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (Ozanimod, Ozanimod , Interferon beta-1a)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • Phoenix, Arizona
  • +298 more
Jan 25, 2021

Atrial Fibrillation Trial in Genk (Heart rhythm measurements with Preventicus®, Heart rhythm measurements with FibriCheck®,

Recruiting
  • Atrial Fibrillation
  • Heart rhythm measurements with Preventicus®
  • +3 more
  • Genk, Limburg, Belgium
    Ziekenhuis Oost-Limburg
Aug 28, 2023

ECMO Braile Biomédica® in COVID-19 Patients

Recruiting
  • COVID-19
  • Patients underwent cardiorespiratory support
  • Lago Sul, Brasília - DF, Brazil
    Hospital Brasília
Oct 13, 2023

Metastatic Gastric Adenocarcinoma, Second Line, Chemo Trial (nal-IRI /Experimental, Ramucirumab /Experimental,

Not yet recruiting
  • Metastatic Gastric Adenocarcinoma
  • +2 more
  • nal-IRI /Experimental
  • +2 more
  • (no location specified)
Jun 25, 2023

Venous Leg Ulcer, Diabetic Foot Trial in Worldwide (AQUACEL® Ag+ Extra™, Cutimed® Sorbact®)

Recruiting
  • Venous Leg Ulcer
  • Diabetic Foot
  • AQUACEL® Ag+ Extra™
  • Cutimed® Sorbact®
  • Barranquilla, Colombia
  • +13 more
May 26, 2023

Dental Implants Trial in L´hospitalet de Llobregat (Dynamic Computer Assisted Surgery, Freehand)

Recruiting
  • Dental Implants
  • Dynamic Computer Assisted Surgery
  • Freehand
  • L´hospitalet de Llobregat, Catalunya, Spain
    University of Barcelona
Aug 31, 2023